Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.2785
+0.0495 (21.62%)
At close: Apr 25, 2025, 4:00 PM
0.2912
+0.0127 (4.56%)
Pre-market: Apr 28, 2025, 5:48 AM EDT

Cyclacel Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
0.040.42---
Upgrade
Revenue Growth (YoY)
-89.76%----
Upgrade
Gross Profit
0.040.42---
Upgrade
Selling, General & Admin
5.396.727.387.465.88
Upgrade
Research & Development
6.6619.1620.2714.934.76
Upgrade
Operating Expenses
12.0525.8727.6622.3910.64
Upgrade
Operating Income
-12-25.45-27.66-22.39-10.64
Upgrade
Interest & Investment Income
0.010.270.210.020.04
Upgrade
Currency Exchange Gain (Loss)
-0.05-0.410.230.040.02
Upgrade
Other Non Operating Income (Expenses)
0.050.051.30.140.89
Upgrade
EBT Excluding Unusual Items
-11.99-25.55-25.92-22.19-9.68
Upgrade
Pretax Income
-11.99-25.55-25.92-22.19-9.68
Upgrade
Income Tax Expense
-0.78-3-4.72-3.73-1.24
Upgrade
Earnings From Continuing Operations
-11.21-22.56-21.2-18.46-8.45
Upgrade
Net Income
-11.21-22.56-21.2-18.46-8.45
Upgrade
Preferred Dividends & Other Adjustments
-0.20.20.23.98
Upgrade
Net Income to Common
-11.21-22.76-21.4-18.66-12.42
Upgrade
Shares Outstanding (Basic)
51110
Upgrade
Shares Outstanding (Diluted)
51110
Upgrade
Shares Change (YoY)
529.44%13.38%26.10%145.67%345.23%
Upgrade
EPS (Basic)
-2.09-26.75-28.52-31.35-51.28
Upgrade
EPS (Diluted)
-2.09-26.75-28.52-31.35-51.30
Upgrade
Free Cash Flow
-7.99-16.12-20.83-18.57-8.03
Upgrade
Free Cash Flow Per Share
-1.49-18.94-27.77-31.20-33.15
Upgrade
Gross Margin
100.00%100.00%---
Upgrade
Operating Margin
-27916.28%-6060.24%---
Upgrade
Profit Margin
-26074.42%-5418.10%---
Upgrade
Free Cash Flow Margin
-18581.40%-3837.62%---
Upgrade
EBITDA
-12-25.42-27.62-22.35-10.62
Upgrade
D&A For EBITDA
0.010.030.030.040.02
Upgrade
EBIT
-12-25.45-27.66-22.39-10.64
Upgrade
Revenue as Reported
0.040.42---
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q